247 724

Cited 0 times in

절제된 IIIA N2 병기 비소세포형 폐암에 있어서 Nodal Station의 의의

DC Field Value Language
dc.contributor.author김길동-
dc.contributor.author김대준-
dc.contributor.author정경영-
dc.date.accessioned2015-07-15T17:17:42Z-
dc.date.available2015-07-15T17:17:42Z-
dc.date.issued2003-
dc.identifier.issn0301-2859-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/114621-
dc.description.abstractTo clarify the prognostic implication of the location and number of the metastatic mediastinal nodes in resected stage IIIA N2 non-small cell lung cancer. Material and Method: One hundred and seventy-four patients with resected non-small cell lung cancer who eventually proved to have pathologic stage IIIA N2 disease were studied. Patients who received preoperative induction therapy, non-curative operation or defined as operative mortality were excluded from this study. Result: In upper lobe tumors, there was no difference in 5-year survival according to the involvement of lower mediastinal nodes (32.3% vs 25.6%, p=0.86). In lower lobe tumors, no difference was found in 5-year survival according to the involvement of upper mediastinal nodes (25.1% vs 14.1%, p=0.33). There was no significant difference in 5-year survival between patients with or without metastatic subcarinal node (20.9% vs 25.6%, p=0.364). In terms of the number of metastatic mediastinal nodes, 5-year survival was better in single station group (26.3%) than multiple station group (18.3%) (p=0.048). In multiple station N2 group, the patients who received postoperative chemotherapy and radiation therapy had better 5-year survival (34.2%) (p=0.01). Cox's proportional hazards model revealed that the age ≥60 (O.R: 1.682, p=.006), multiple station N2 (O.R: 1.503. p=0.021), pneumonectomy (O.R: 1.562, p=0.018), postoperative chemotherapy and radiation therapy (O.R: 0.625, p=0.012) were the factors affecting the postoperative survival. Conclusion: Multiple station N2 disease was the important prognostic factor for postoperative survival in resected stage IIIA N2 non-small cell lung cancer. Postoperative chemotherapy and radiotherapy were thought to improve the survival in case of multiple station N2 disease.-
dc.description.statementOfResponsibilityopen-
dc.formatapplication/pdf-
dc.relation.isPartOfKorean Journal of Thoracic and Cardiovascular Surgery (대한흉부외과학회지)-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHNeoplasm staging-
dc.subject.MESHCarcinoma-
dc.subject.MESHnon-small cell-
dc.subject.MESHlung-
dc.subject.MESHLymph node-
dc.title절제된 IIIA N2 병기 비소세포형 폐암에 있어서 Nodal Station의 의의-
dc.title.alternativeNodal Station as a Prognostic Factor in Resected Stage IIIA N2 Non-Small Cell Lung Cancer-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Thoracic & Cardiovascular Surgery (흉부외과학)-
dc.contributor.googleauthor김대준-
dc.contributor.googleauthor김길동-
dc.contributor.googleauthor정경영-
dc.contributor.googleauthor김치영-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00346-
dc.contributor.localIdA00368-
dc.contributor.localIdA03571-
dc.relation.journalcodeJ02127-
dc.subject.keywordNeoplasm staging-
dc.subject.keywordCarcinoma-
dc.subject.keywordnon-small cell-
dc.subject.keywordlung-
dc.subject.keywordLymph node-
dc.contributor.alternativeNameKim, Kil Dong-
dc.contributor.alternativeNameKim, Dae Joon-
dc.contributor.alternativeNameChung, Kyung Young-
dc.contributor.affiliatedAuthorKim, Kil Dong-
dc.contributor.affiliatedAuthorKim, Dae Joon-
dc.contributor.affiliatedAuthorChung, Kyung Young-
dc.rights.accessRightsfree-
dc.citation.volume36-
dc.citation.number7-
dc.citation.startPage489-
dc.citation.endPage496-
dc.identifier.bibliographicCitationKorean Journal of Thoracic and Cardiovascular Surgery (대한흉부외과학회지), Vol.36(7) : 489-496, 2003-
dc.identifier.rimsid40072-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Thoracic and Cardiovascular Surgery (흉부외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.